Bristol-Myers Squibb Target Price

Bristol-Myers Squibb's target price stands at $69. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $69 for BMY implies 10.1% upside versus today's price ($62.86). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Bristol-Myers Squibb's target price evolved across reporting periods, while the comparison chart places BMY next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Bristol-Myers Squibb's reading of $69 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.